 | • レポートコード：MRC2012A0718 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、オーロラキナーゼBの世界市場を広く調査・分析し、今後の市場展望をまとめております。オーロラキナーゼBの種類別市場規模（AZD-2811、CS-2164、Danusertib、Ilorasertib、NMI-900、その他）、用途別市場規模（未分化大細胞リンパ腫、腎臓がん、肺がん、前立腺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie Inc、Sanofi、Amgen Inc、Advenchen Laboratories LLC、Cielo Therapeutics Inc、Aeterna Zentaris Inc、Chipscreen Biosciences Ltd、AstraZeneca Plc、Sareum Holdings Plc、 ・地域別グローバル市場分析 2015年-2020年 ・オーロラキナーゼBの北米市場（アメリカ、カナダ、メキシコ） ・オーロラキナーゼBのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オーロラキナーゼBのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オーロラキナーゼBの南米市場（ブラジル、アルゼンチン） ・オーロラキナーゼBの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：AZD-2811、CS-2164、Danusertib、Ilorasertib、NMI-900、その他 ・用途別分析：未分化大細胞リンパ腫、腎臓がん、肺がん、前立腺がん、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Aurora Kinase B market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Aurora Kinase B market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Aurora Kinase B market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Aurora Kinase B market has been segmented into
AZD-2811
CS-2164
Danusertib
Ilorasertib
NMI-900
Others
By Application, Aurora Kinase B has been segmented into:
Anaplastic Large Cell Lymphoma
Kidney Cancer
Lung Cancer
Prostate Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Aurora Kinase B market presented in the report. This section sheds light on the sales growth of different regional and country-level Aurora Kinase B markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Aurora Kinase B market.
The report offers in-depth assessment of the growth and other aspects of the Aurora Kinase B market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Aurora Kinase B Market Share Analysis
Aurora Kinase B competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Aurora Kinase B sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Aurora Kinase B sales, revenue and market share for each player covered in this report.
The major players covered in Aurora Kinase B are:
AbbVie Inc
Sanofi
Amgen Inc
Advenchen Laboratories LLC
Cielo Therapeutics Inc
Aeterna Zentaris Inc
Chipscreen Biosciences Ltd
AstraZeneca Plc
Sareum Holdings Plc
Among other players domestic and global, Aurora Kinase B market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aurora Kinase B product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aurora Kinase B, with price, sales, revenue and global market share of Aurora Kinase B in 2018 and 2019.
Chapter 3, the Aurora Kinase B competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aurora Kinase B breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Aurora Kinase B market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Aurora Kinase B sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Aurora Kinase B Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Aurora Kinase B Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AZD-2811
1.2.3 CS-2164
1.2.4 Danusertib
1.2.5 Ilorasertib
1.2.6 NMI-900
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Aurora Kinase B Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anaplastic Large Cell Lymphoma
1.3.3 Kidney Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Overview of Global Aurora Kinase B Market
1.4.1 Global Aurora Kinase B Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie Inc SWOT Analysis
2.1.4 AbbVie Inc Product and Services
2.1.5 AbbVie Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen Inc
2.3.1 Amgen Inc Details
2.3.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen Inc SWOT Analysis
2.3.4 Amgen Inc Product and Services
2.3.5 Amgen Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advenchen Laboratories LLC
2.4.1 Advenchen Laboratories LLC Details
2.4.2 Advenchen Laboratories LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advenchen Laboratories LLC SWOT Analysis
2.4.4 Advenchen Laboratories LLC Product and Services
2.4.5 Advenchen Laboratories LLC Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cielo Therapeutics Inc
2.5.1 Cielo Therapeutics Inc Details
2.5.2 Cielo Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cielo Therapeutics Inc SWOT Analysis
2.5.4 Cielo Therapeutics Inc Product and Services
2.5.5 Cielo Therapeutics Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aeterna Zentaris Inc
2.6.1 Aeterna Zentaris Inc Details
2.6.2 Aeterna Zentaris Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aeterna Zentaris Inc SWOT Analysis
2.6.4 Aeterna Zentaris Inc Product and Services
2.6.5 Aeterna Zentaris Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Chipscreen Biosciences Ltd
2.7.1 Chipscreen Biosciences Ltd Details
2.7.2 Chipscreen Biosciences Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Chipscreen Biosciences Ltd SWOT Analysis
2.7.4 Chipscreen Biosciences Ltd Product and Services
2.7.5 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca Plc
2.8.1 AstraZeneca Plc Details
2.8.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca Plc SWOT Analysis
2.8.4 AstraZeneca Plc Product and Services
2.8.5 AstraZeneca Plc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sareum Holdings Plc
2.9.1 Sareum Holdings Plc Details
2.9.2 Sareum Holdings Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sareum Holdings Plc SWOT Analysis
2.9.4 Sareum Holdings Plc Product and Services
2.9.5 Sareum Holdings Plc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Aurora Kinase B Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Aurora Kinase B Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Aurora Kinase B Manufacturer Market Share in 2019
3.3.2 Top 6 Aurora Kinase B Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Aurora Kinase B Sales, Revenue and Market Share by Regions
4.1.1 Global Aurora Kinase B Sales and Market Share by Regions (2015-2020)
4.1.2 Global Aurora Kinase B Revenue and Market Share by Regions (2015-2020)
4.2 North America Aurora Kinase B Sales and Growth Rate (2015-2020)
4.3 Europe Aurora Kinase B Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Aurora Kinase B Sales and Growth Rate (2015-2020)
4.5 South America Aurora Kinase B Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Aurora Kinase B Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Aurora Kinase B Sales, Revenue and Market Share by Country
5.1.1 North America Aurora Kinase B Sales and Market Share by Country (2015-2020)
5.1.2 North America Aurora Kinase B Revenue and Market Share by Country (2015-2020)
5.2 United States Aurora Kinase B Sales and Growth Rate (2015-2020)
5.3 Canada Aurora Kinase B Sales and Growth Rate (2015-2020)
5.4 Mexico Aurora Kinase B Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Aurora Kinase B Sales, Revenue and Market Share by Country
6.1.1 Europe Aurora Kinase B Sales and Market Share by Country (2015-2020)
6.1.2 Europe Aurora Kinase B Revenue and Market Share by Country (2015-2020)
6.2 Germany Aurora Kinase B Sales and Growth Rate (2015-2020)
6.3 UK Aurora Kinase B Sales and Growth Rate (2015-2020)
6.4 France Aurora Kinase B Sales and Growth Rate (2015-2020)
6.5 Russia Aurora Kinase B Sales and Growth Rate (2015-2020)
6.6 Italy Aurora Kinase B Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Aurora Kinase B Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Aurora Kinase B Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Aurora Kinase B Revenue and Market Share by Regions (2015-2020)
7.2 China Aurora Kinase B Sales and Growth Rate (2015-2020)
7.3 Japan Aurora Kinase B Sales and Growth Rate (2015-2020)
7.4 Korea Aurora Kinase B Sales and Growth Rate (2015-2020)
7.5 India Aurora Kinase B Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Aurora Kinase B Sales and Growth Rate (2015-2020)
7.7 Australia Aurora Kinase B Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Aurora Kinase B Sales, Revenue and Market Share by Country
8.1.1 South America Aurora Kinase B Sales and Market Share by Country (2015-2020)
8.1.2 South America Aurora Kinase B Revenue and Market Share by Country (2015-2020)
8.2 Brazil Aurora Kinase B Sales and Growth Rate (2015-2020)
8.3 Argentina Aurora Kinase B Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Aurora Kinase B Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Aurora Kinase B Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Aurora Kinase B Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Aurora Kinase B Sales and Growth Rate (2015-2020)
9.3 Turkey Aurora Kinase B Sales and Growth Rate (2015-2020)
9.4 Egypt Aurora Kinase B Sales and Growth Rate (2015-2020)
9.5 South Africa Aurora Kinase B Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Aurora Kinase B Sales and Market Share by Type (2015-2020)
10.2 Global Aurora Kinase B Revenue and Market Share by Type (2015-2020)
10.3 Global Aurora Kinase B Price by Type (2015-2020)
11 Global Aurora Kinase B Market Segment by Application
11.1 Global Aurora Kinase B Sales Market Share by Application (2015-2020)
11.2 Global Aurora Kinase B Revenue Market Share by Application (2015-2020)
11.3 Global Aurora Kinase B Price by Application (2015-2020)
12 Market Forecast
12.1 Global Aurora Kinase B Sales, Revenue and Growth Rate (2021-2025)
12.2 Aurora Kinase B Market Forecast by Regions (2021-2025)
12.2.1 North America Aurora Kinase B Market Forecast (2021-2025)
12.2.2 Europe Aurora Kinase B Market Forecast (2021-2025)
12.2.3 Asia-Pacific Aurora Kinase B Market Forecast (2021-2025)
12.2.4 South America Aurora Kinase B Market Forecast (2021-2025)
12.2.5 Middle East & Africa Aurora Kinase B Market Forecast (2021-2025)
12.3 Aurora Kinase B Market Forecast by Type (2021-2025)
12.3.1 Global Aurora Kinase B Sales Forecast by Type (2021-2025)
12.3.2 Global Aurora Kinase B Market Share Forecast by Type (2021-2025)
12.4 Aurora Kinase B Market Forecast by Application (2021-2025)
12.4.1 Global Aurora Kinase B Sales Forecast by Application (2021-2025)
12.4.2 Global Aurora Kinase B Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Aurora Kinase B Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Aurora Kinase B by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Aurora Kinase B Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Inc Aurora Kinase B Major Business
Table 9. AbbVie Inc Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie Inc SWOT Analysis
Table 11. AbbVie Inc Aurora Kinase B Product and Services
Table 12. AbbVie Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Aurora Kinase B Major Business
Table 15. Sanofi Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi SWOT Analysis
Table 17. Sanofi Aurora Kinase B Product and Services
Table 18. Sanofi Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Inc Aurora Kinase B Major Business
Table 21. Amgen Inc Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 22. Amgen Inc SWOT Analysis
Table 23. Amgen Inc Aurora Kinase B Product and Services
Table 24. Amgen Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Advenchen Laboratories LLC Basic Information, Manufacturing Base and Competitors
Table 26. Advenchen Laboratories LLC Aurora Kinase B Major Business
Table 27. Advenchen Laboratories LLC Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 28. Advenchen Laboratories LLC SWOT Analysis
Table 29. Advenchen Laboratories LLC Aurora Kinase B Product and Services
Table 30. Advenchen Laboratories LLC Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Cielo Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. Cielo Therapeutics Inc Aurora Kinase B Major Business
Table 33. Cielo Therapeutics Inc Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 34. Cielo Therapeutics Inc SWOT Analysis
Table 35. Cielo Therapeutics Inc Aurora Kinase B Product and Services
Table 36. Cielo Therapeutics Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Aeterna Zentaris Inc Basic Information, Manufacturing Base and Competitors
Table 38. Aeterna Zentaris Inc Aurora Kinase B Major Business
Table 39. Aeterna Zentaris Inc Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 40. Aeterna Zentaris Inc SWOT Analysis
Table 41. Aeterna Zentaris Inc Aurora Kinase B Product and Services
Table 42. Aeterna Zentaris Inc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Chipscreen Biosciences Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Chipscreen Biosciences Ltd Aurora Kinase B Major Business
Table 45. Chipscreen Biosciences Ltd Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 46. Chipscreen Biosciences Ltd SWOT Analysis
Table 47. Chipscreen Biosciences Ltd Aurora Kinase B Product and Services
Table 48. Chipscreen Biosciences Ltd Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 50. AstraZeneca Plc Aurora Kinase B Major Business
Table 51. AstraZeneca Plc Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 52. AstraZeneca Plc SWOT Analysis
Table 53. AstraZeneca Plc Aurora Kinase B Product and Services
Table 54. AstraZeneca Plc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sareum Holdings Plc Basic Information, Manufacturing Base and Competitors
Table 56. Sareum Holdings Plc Aurora Kinase B Major Business
Table 57. Sareum Holdings Plc Aurora Kinase B Total Revenue (USD Million) (2017-2018)
Table 58. Sareum Holdings Plc SWOT Analysis
Table 59. Sareum Holdings Plc Aurora Kinase B Product and Services
Table 60. Sareum Holdings Plc Aurora Kinase B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Aurora Kinase B Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global Aurora Kinase B Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Aurora Kinase B Sales by Regions (2015-2020) (K Pcs)
Table 64. Global Aurora Kinase B Sales Market Share by Regions (2015-2020)
Table 65. Global Aurora Kinase B Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Aurora Kinase B Sales by Countries (2015-2020) (K Pcs)
Table 67. North America Aurora Kinase B Sales Market Share by Countries (2015-2020)
Table 68. North America Aurora Kinase B Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Aurora Kinase B Revenue Market Share by Countries (2015-2020)
Table 70. Europe Aurora Kinase B Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe Aurora Kinase B Sales Market Share by Countries (2015-2020)
Table 72. Europe Aurora Kinase B Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Aurora Kinase B Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific Aurora Kinase B Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Aurora Kinase B Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Aurora Kinase B Sales by Countries (2015-2020) (K Pcs)
Table 77. South America Aurora Kinase B Sales Market Share by Countries (2015-2020)
Table 78. South America Aurora Kinase B Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Aurora Kinase B Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Aurora Kinase B Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa Aurora Kinase B Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Aurora Kinase B Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Aurora Kinase B Revenue Market Share by Countries (2015-2020)
Table 84. Global Aurora Kinase B Sales by Type (2015-2020) (K Pcs)
Table 85. Global Aurora Kinase B Sales Share by Type (2015-2020)
Table 86. Global Aurora Kinase B Revenue by Type (2015-2020) (USD Million)
Table 87. Global Aurora Kinase B Revenue Share by Type (2015-2020)
Table 88. Global Aurora Kinase B Sales by Application (2015-2020) (K Pcs)
Table 89. Global Aurora Kinase B Sales Share by Application (2015-2020)
Table 90. Global Aurora Kinase B Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global Aurora Kinase B Market Share Forecast by Regions (2021-2025)
Table 92. Global Aurora Kinase B Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global Aurora Kinase B Market Share Forecast by Type (2021-2025)
Table 94. Global Aurora Kinase B Sales Forecast by Application (2021-2025)
Table 95. Global Aurora Kinase B Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Aurora Kinase B Picture
Figure 2. Global Sales Market Share of Aurora Kinase B by Type in 2019
Figure 3. AZD-2811 Picture
Figure 4. CS-2164 Picture
Figure 5. Danusertib Picture
Figure 6. Ilorasertib Picture
Figure 7. NMI-900 Picture
Figure 8. Others Picture
Figure 9. Aurora Kinase B Sales Market Share by Application in 2018
Figure 10. Anaplastic Large Cell Lymphoma Picture
Figure 11. Kidney Cancer Picture
Figure 12. Lung Cancer Picture
Figure 13. Prostate Cancer Picture
Figure 14. Others Picture
Figure 15. Global Aurora Kinase B Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Aurora Kinase B Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Aurora Kinase B Sales Market Share by Manufacturer in 2019
Figure 36. Global Aurora Kinase B Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Aurora Kinase B Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Aurora Kinase B Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 41. Global Aurora Kinase B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Aurora Kinase B Revenue Market Share by Regions (2015-2020)
Figure 43. Global Aurora Kinase B Revenue Market Share by Regions in 2018
Figure 44. North America Aurora Kinase B Sales and Growth Rate (2015-2020)
Figure 45. Europe Aurora Kinase B Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Aurora Kinase B Sales and Growth Rate (2015-2020)
Figure 47. South America Aurora Kinase B Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Aurora Kinase B Sales and Growth Rate (2015-2020)
Figure 49. North America Aurora Kinase B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Aurora Kinase B Sales Market Share by Countries (2015-2020)
Figure 51. North America Aurora Kinase B Sales Market Share by Countries in 2018
Figure 52. North America Aurora Kinase B Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Aurora Kinase B Revenue Market Share by Countries in 2018
Figure 54. United States Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Canada Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Mexico Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Europe Aurora Kinase B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Aurora Kinase B Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Aurora Kinase B Revenue Market Share by Countries in 2019
Figure 60. Germany Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. UK Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. France Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Italy Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Asia-Pacific Aurora Kinase B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Aurora Kinase B Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Aurora Kinase B Revenue Market Share by Regions 2019
Figure 68. China Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Korea Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. India Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Southeast Asia Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. South America Aurora Kinase B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Aurora Kinase B Sales Market Share by Countries in 2019
Figure 75. South America Aurora Kinase B Revenue Market Share by Countries in 2019
Figure 76. Brazil Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Argentina Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Middle East and Africa Aurora Kinase B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Aurora Kinase B Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Aurora Kinase B Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Aurora Kinase B Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Egypt Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Turkey Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. South Africa Aurora Kinase B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Global Aurora Kinase B Sales and Growth Rate (2021-2025) (K Pcs)
Figure 87. Global Aurora Kinase B Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Aurora Kinase B Market Forecast (2021-2025) (K Pcs)
Figure 89. Europe Sales Aurora Kinase B Market Forecast (2021-2025) (K Pcs)
Figure 90. Asia-Pacific Sales Aurora Kinase B Market Forecast (2021-2025) (K Pcs)
Figure 91. South America Sales Aurora Kinase B Market Forecast (2021-2025) (K Pcs)
Figure 92. Middle East & Africa Sales Aurora Kinase B Market Forecast (2021-2025) (K Pcs)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
オーロラキナーゼBの世界市場（～2026年） Market Analysis and Insights: Global Aurora Kinase B Market The global Aurora Kinase B market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Aurora Kinase B Scope and Market Size Aurora Kinase B market is segmented by Type, …- オーロラキナーゼCの世界市場（～2026年） Market Analysis and Insights: Global Aurora Kinase C Market The global Aurora Kinase C market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Aurora Kinase C Scope and Market Size Aurora Kinase C market is segmented by Type, …
- オーロラキナーゼAの世界市場（～2026年） Market Analysis and Insights: Global Aurora Kinase A Market The global Aurora Kinase A market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Aurora Kinase A Scope and Market Size Aurora Kinase A market is segmented by Type, …
- 癌治療用ヤヌスキナーゼ阻害剤の世界市場（～2026年） Cancer Janus Kinase Inhibitors The conventional modes of cancer management including surgery, radiotherapy and chemotherapy were discarded as an aspirant for the future of cancer management long back ago. The arrival of modern cancer treatment modalities like immunotherapy and targeted therapy revol…
- 細胞分裂周期7関連プロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global Cell Division Cycle 7 Related Protein Kinase Market The global Cell Division Cycle 7 Related Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cell Division Cycle 7 Rel…